Virios Therapeutics (VIRI) Stock Chart & Stock Price History $6.41 -0.01 (-0.16%) As of 10/3/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock Virios Therapeutics Stock Price Performance The Virios Therapeutics (VIRI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 3,626.74%, with a year-to-date return of 124.91%. In the past month, the stock has increased 30.15%, reflecting recent market activity. As of the latest close, Virios Therapeutics traded at $6.42 with a market cap of $123.64 million and volume of 170,210 shares. Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+16.12%1 Month Performance+30.15%3 Month Performance+32.71%Year-To-Date Performance+124.91%1 Year Performance+3,626.74% VIRI Stock Chart for Saturday, October, 4, 2025 VIRI Chart by TradingView Virios Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$7.07$6.42-9.19%$7.30$6.40170,210 shs$123.64 million10/02/2025$7.70$7.07-8.18%$8.49$6.88997,657 shs$136.15 million10/01/2025$7.91$7.70-2.65%$8.10$7.46629,589 shs$148.29 million09/30/2025$5.52$7.91+43.30%$9.50$7.0743.11 million shs$152.33 million09/29/2025$5.52$5.52$5.81$4.9768,924 shs$106.30 million09/26/2025$5.15$5.11-0.78%$5.18$4.9226,192 shs$98.41 million09/25/2025$5.03$5.15+2.33%$5.24$5.0511,200 shs$99.18 million09/24/2025$5.18$5.03-2.85%$5.25$4.9042,494 shs$96.92 million09/23/2025$5.01$5.18+3.39%$5.19$4.8822,401 shs$99.76 million09/22/2025$5.01$5.01$5.15$4.8230,896 shs$96.48 million Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$4.90$4.81-1.75%$5.00$4.7825,877 shs$92.72 million09/18/2025$4.88$4.90+0.41%$5.05$4.9014,024 shs$94.36 million09/17/2025$4.87$4.88+0.20%$4.98$4.884,998 shs$93.98 million09/16/2025$4.89$4.87-0.40%$5.00$4.778,645 shs$93.79 million09/15/2025$4.89$4.89$5.00$4.7717,500 shs$94.17 million09/12/2025$4.86$4.90+0.76%$4.90$4.842,349 shs$94.30 million09/11/2025$4.83$4.86+0.62%$4.93$4.777,700 shs$93.59 million09/10/2025$4.90$4.83-1.43%$4.92$4.775,412 shs$93.02 million09/09/2025$4.90$4.90$4.94$4.806,508 shs$94.36 million09/08/2025$4.90$4.90$4.95$4.875,981 shs$94.36 million09/05/2025$4.93$5.00+1.52%$5.02$4.835,961 shs$96.29 million09/04/2025$4.81$4.93+2.39%$4.98$4.836,065 shs$94.85 million09/03/2025$4.96$4.81-3.02%$5.00$4.812,554 shs$92.63 million Related Companies Rapt Therapeutics Stock Price Chart Bright Minds Biosciences Stock Price Chart Korro Bio Stock Price Chart Astria Therapeutics Stock Price Chart Design Therapeutics Stock Price Chart Alumis Stock Price Chart Kamada Stock Price Chart Evolus Stock Price Chart MoonLake Immunotherapeutics Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRI) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersChina’s New Gold Play Could Make your Income SoarChina's New Gold Move Could Pay You up to $1,152/month. China just announced plans to store other nations' ...Investors Alley | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virios Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
